This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Apr;4(4):249-58.

doi: 10.1038/nri1329.

Immunotherapeutic uses of CpG oligodeoxynucleotides

Dennis M Klinman¹

Affiliations

PMID: 15057783
DOI: 10.1038/nri1329

Review

Immunotherapeutic uses of CpG oligodeoxynucleotides

Dennis M Klinman. Nat Rev Immunol. 2004 Apr.

. 2004 Apr;4(4):249-58.

doi: 10.1038/nri1329.

Author

Dennis M Klinman¹

Affiliation

¹ CBER/FDA, Bethesda, Maryland 20892, USA. klinman@cber.FDA.gov

PMID: 15057783
DOI: 10.1038/nri1329

No abstract available

PubMed Disclaimer

Similar articles

Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma.
Ursu R, Carpentier AF. Ursu R, et al. Adv Exp Med Biol. 2012;746:95-108. doi: 10.1007/978-1-4614-3146-6_8. Adv Exp Med Biol. 2012. PMID: 22639162 Review.
Immunostimulatory CpG oligodeoxynucleotides and antibody therapy of cancer.
Jahrsdörfer B, Weiner GJ. Jahrsdörfer B, et al. Semin Oncol. 2003 Aug;30(4):476-82. doi: 10.1016/s0093-7754(03)00236-7. Semin Oncol. 2003. PMID: 12939716 Review.
CpG-oligonucleotides for cancer immunotherapy : review of the literature and potential applications in malignant glioma.
Carpentier AF, Auf G, Delattre JY. Carpentier AF, et al. Front Biosci. 2003 Jan 1;8:e115-27. doi: 10.2741/934. Front Biosci. 2003. PMID: 12456326 Review.
Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model.
Kootiratrakarn T, Fujimura T, Sano K, Okuyama R, Aiba S, Tagami H, Terui T. Kootiratrakarn T, et al. Eur J Immunol. 2005 Nov;35(11):3277-86. doi: 10.1002/eji.200526274. Eur J Immunol. 2005. PMID: 16245360
Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9.
Takeshita F, Gursel I, Ishii KJ, Suzuki K, Gursel M, Klinman DM. Takeshita F, et al. Semin Immunol. 2004 Feb;16(1):17-22. doi: 10.1016/j.smim.2003.10.009. Semin Immunol. 2004. PMID: 14751759 Review.

See all similar articles

Cited by

Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes.
Henault J, Martinez J, Riggs JM, Tian J, Mehta P, Clarke L, Sasai M, Latz E, Brinkmann MM, Iwasaki A, Coyle AJ, Kolbeck R, Green DR, Sanjuan MA. Henault J, et al. Immunity. 2012 Dec 14;37(6):986-997. doi: 10.1016/j.immuni.2012.09.014. Epub 2012 Dec 6. Immunity. 2012. PMID: 23219390 Free PMC article.
Optically Triggered Immune Response through Photocaged Oligonucleotides.
Govan JM, Young DD, Lively MO, Deiters A. Govan JM, et al. Tetrahedron Lett. 2015 Jun 3;56(23):3639-3642. doi: 10.1016/j.tetlet.2015.01.165. Tetrahedron Lett. 2015. PMID: 26034339 Free PMC article.
Synergistic Effects of Metal-Organic Nanoplatform and Guanine Quadruplex-Based CpG Oligodeoxynucleotides in Therapeutic Cancer Vaccines with Different Tumor Antigens.
Li X, Ebara M, Shirahata N, Yamazaki T, Hanagata N. Li X, et al. Vaccines (Basel). 2024 Jun 11;12(6):649. doi: 10.3390/vaccines12060649. Vaccines (Basel). 2024. PMID: 38932378 Free PMC article.
NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses.
Zhang L, Zhang J, Xu L, Zhuang Z, Liu J, Liu S, Wu Y, Gong A, Zhang M, Du F. Zhang L, et al. J Nanobiotechnology. 2021 May 17;19(1):142. doi: 10.1186/s12951-021-00880-x. J Nanobiotechnology. 2021. PMID: 34001148 Free PMC article.
Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
Marshall JD, Heeke DS, Abbate C, Yee P, Van Nest G. Marshall JD, et al. Immunology. 2006 Jan;117(1):38-46. doi: 10.1111/j.1365-2567.2005.02261.x. Immunology. 2006. PMID: 16423039 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database